Trials / Completed
CompletedNCT02502019
HEMOBLAST Pilot Clinical Investigation
Prospective, Multicenter, Single-arm Pilot Clinical Investigation Evaluating the Use of a Surface Bleeding Severity Scale (SBSS) and the Safety and Efficacy of a New Hemostatic Device in Abdominal and Orthopedic Lower Extremity Surgeries
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 27 (actual)
- Sponsor
- Biom'Up France SAS · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this pilot clinical investigation is to assess the reliability of the Surface Bleeding Severity Scale (SBSS) in a clinical setting. Secondary objectives of this clinical investigation are to collect initial data on the safety and efficacy of HEMOBLAST™ Bellows in abdominal and orthopedic lower extremity surgeries.
Detailed description
HEMOBLAST™ Bellows is intended for use in surgical procedures as an adjunct to hemostasis when control of bleeding by conventional procedures is ineffective or impractical. This is a prospective, multicenter, single-arm pilot clinical investigation. There will be 36 subjects enrolled across 4 investigational sites. The subjects will be followed at hospital charge and 6 weeks postoperatively. The primary endpoint of this clinical investigation is the mean paired Kappa statistic for the assignment of SBSS scores by 2 Investigators. Secondary endpoints of this clinical investigation consist of: * Proportion of subjects achieving hemostasis within 6 minutes of HEMOBLAST™ Bellows application; * Proportion of subjects achieving hemostasis within 10 minutes of HEMOBLAST™ Bellows application; * Proportion of subjects achieving hemostasis within 3 minutes of HEMOBLAST™ Bellows application; and * Incidence of adverse events through final follow-up.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | HEMOBLAST Bellows | HEMOBLAST™ Bellows is intended for use in surgical procedures as an adjunct to hemostasis when control of bleeding by conventional procedures is ineffective or impractical. |
Timeline
- Start date
- 2015-08-01
- Primary completion
- 2016-03-01
- Completion
- 2016-03-01
- First posted
- 2015-07-17
- Last updated
- 2019-02-15
- Results posted
- 2019-02-15
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02502019. Inclusion in this directory is not an endorsement.